Suppression of inflammatory and immune responses by the A2Aadenosine receptor: an introduction
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The purine nucleoside adenosine has been described as a ‘retaliatory metabolite’ by virtue of its ability to function in an autocrine manner to modify the activity of a range of cell types following its extracellular accumulation during cell stress or injury. These effects are largely protective and are triggered by the binding of adenosine to any of four G‐protein‐coupled adenosine receptors. Most of the anti‐inflammatory effects of adenosine have been assigned to the adenosine A 2A receptor subtype, which is expressed in many immune and inflammatory cells. In this brief article, we will outline the growing evidence to support the hypothesis that the development of agonists selective for the A 2A receptor is an effective strategy for suppressing the exaggerated inflammatory responses associated with many diseases by virtue of the receptor's ability to inhibit multiple pro‐inflammatory signalling cascades. British Journal of Pharmacology(2008)153, S27–S34; doi:10.1038/sj.bjp.0707524; published online 19 November 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 2×
“induction, the SH2 domain binds to specific phosphor-Tyr residues present on target cytokine receptors, such as gp130 and the leptin receptor Ob-R (Heinrich et al., 2003) (Figure 1).”
BackgroundInternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580 · cited 4×
“SOCS-3 is one of the eight SOCS family members (cytokine-inducible SH2 domain protein, SOCS-1 to -7) defined by the presence of a distinct N-terminal region linked to a central SH2 and C-terminal SOCS box domains (Yoshimura et al., 2007).”
BackgroundInfluentialCoordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium
Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C., & Colgan, S. P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030891 · Cited by 499 · cited 2×
“…has been elegantly demonstrated by gene-targeting studies in mice, which have shown that the presence of functional CD39 and CD73 is necessary to maintain endothelial barrier function and thus prevent excessive vascular leakage following hypoxia (Eltzschig et al., 2003; Thompson et al., 2004).”
BackgroundPinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278 · cited 2×
“In contrast, the receptor is largely absent from B cells (Koshiba et al., 1999; Sullivan et al., 2001; Pinhal-Enfield et al., 2003; Zhang et al., 2005; Raskovalova et al., 2006).”
Background
Cited by
Recent developments in adenosine receptor ligands and their potential as novel drugs
Müller, C. E., & Jacobson, K. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.017 · Cited by 431
Immunosuppressive Activities of Adenosine in Cancer
Allard, B., Beavis, P. A., Darcy, P. K., & Stagg, J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.04.001 · Cited by 292
Adenosine: An endogenous modulator of innate immune system with therapeutic potential
Kumar, V., & Sharma, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.005 · Cited by 177
Jo, S., Baek, A., Cho, Y., Kim, S. H., Baek, D., Hwang, J., Cho, S.-R., & Kim, H. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-32744-9 · Cited by 19
Anti Inflammatory Property of PDRN—An in Vitro Study on Cultured Macrophages
Castellini, C., Belletti, S., Govoni, P., & Guizzardi, S. (2017) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2017.81002 · Cited by 17
“Several studies have indicated that adenosine is involved in the modulation of the inflammatory process [17], e.”
Background
Metadata
- Authors
- Palmer, T. M., & Trevethick, M. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- S1
- Pages
- S27-34
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1554232669
- Cited by
- 68
- References
- 5
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.